Industry News
-
Pioneering Organoid Research at the“Organoids Are Us”Conference in Thailand: A Collaborative Endeavor to Drive Scientific Innovation
The "Organoids Are Us" symposium, held in the picturesque setting of Pattaya, Thailand, has successfully concluded, marking a significant milestone in the field of organoid research. The International Society of Organoid Research (ISoOR) was honored to be invited and to present at the conference.
Journal of Organoid & Bioscience | Volume 2 Number 1 Live Now!
International Society of Organoid Research (ISoOR) proudly announces the publication of Volume 2, Number 1 of its esteemed journal, Journal of Organoid & Bioscience.
Innovating the Future: ISoOR 2024 Annual Meeting Achieves Remarkable Success
From March 7 to 8, 2024, the International Society of Organoid Research (ISoOR) convened its 2024 annual meeting, after the successful conference in Singapore last year.
A New Frontier in Science: ISoOR Launches Journal of Organoid & Bioscience
The International Society of Organoid Research (ISoOR) recently marked a significant advancement in the organoid field with the introduction of its new publication: Journal of Organoid & Bioscience (JOBs).
Valo Health Bags $2.7bn AI Partnership with Novo Nordisk
Novo Nordisk has paid $60 million to partner Valo Health on a project that will apply the US start-up's artificial intelligence-powered drug discovery engine to find new therapies for cardiometabolic diseases.
Valo Health Bags $2.7bn AI Partnership with Novo Nordisk
Novo Nordisk has paid $60 million to partner Valo Health on a project that will apply the US start-up's artificial intelligence-powered drug discovery engine to find new therapies for cardiometabolic diseases.
Organoids Making Their US Clinical Debut with CIDP Drug
The use of organoids in preclinical research has reached a tipping point, with U.S. FDA approval of the first drug to enter clinical trials on the basis of efficacy data derived only from these advanced cell models.